Literature DB >> 6814376

The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.

V Kalff, B Shapiro, R Lloyd, J C Sisson, K Holland, M Nakajo, W H Beierwaltes.   

Abstract

We have found an appreciable number of pheochromocytomas in patients with neurofibromatosis and concurrent hypertension (ten of 18 cases). At diagnosis, the patient age range was 15 to 62 years, the clinical appearance of the neurofibromatosis did not predict who would and who would not have pheochromocytomas, but the age at diagnosis was helpful in that our younger patients tended to have causes of hypertension other than pheochromocytoma. However, several causes of hypertension may coexist. The biochemical findings were highly diagnostic. The pheochromocytomas secreted epinephrine as well as norepinephrine and resided in or next to the adrenal gland. Where pheochromocytoma is the cause of hypertension, its resection generally results in a better control of hypertension than that obtained in patients whose BPs were elevated from other unknown causes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814376

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Abdominal tumours and neurofibromatosis.

Authors:  A J Martin; R C Williamson
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

2.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 3.  Rethinking pheochromocytomas and paragangliomas from a genomic perspective.

Authors:  L J Castro-Vega; C Lepoutre-Lussey; A-P Gimenez-Roqueplo; J Favier
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 4.  Peripheral nerve tumors: management strategies and molecular insights.

Authors:  Asis Kumar Bhattacharyya; Richard Perrin; Abhijit Guha
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

Review 5.  Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature.

Authors:  C Erem; H Onder Ersöz; K Ukinç; A Hacihasanoglu; E Alhan; U Cobanoğlu; M Koçak; H Erdöl
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

6.  Bilateral pheochromocytomas.

Authors:  V Kalff; B Shapiro; R Lloyd; M Nakajo; J C Sisson; W H Beierwaltes
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

7.  Phaeochromocytoma: report of three cases.

Authors:  D Lewis; N Dalton; S Rigden
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

8.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

9.  Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1.

Authors:  Cleandra Gregório; Clévia Rosset; Laura da Silva Alves; Cristina Brinkmann Oliveira Netto; Simone Marcia Dos Santos Machado; Vivian Pierri Bersch; Alessandro Bersch Osvaldt; Patricia Ashton-Prolla
Journal:  Front Genet       Date:  2020-04-28       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.